A Chemical Chaperone-Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Chemical Chaperone-Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
Authors
Keywords
-
Journal
ChemMedChem
Volume 10, Issue 5, Pages 850-861
Publisher
Wiley
Online
2015-03-14
DOI
10.1002/cmdc.201500045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis
- (2014) Paul C. Trippier et al. ACS Chemical Neuroscience
- Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic β-cells via AMPK activation
- (2014) L. Pasternak et al. CHEMICAL COMMUNICATIONS
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
- (2014) Steve Vucic et al. TRENDS IN NEUROSCIENCES
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cis-suppression to arrest protein aggregation in mammalian cells
- (2013) Simpson Gregoire et al. BIOTECHNOLOGY AND BIOENGINEERING
- SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status
- (2013) Yuewei Sheng et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes
- (2013) Manuela Basso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyotrophic lateral sclerosis: an update on recent genetic insights
- (2013) Yohei Iguchi et al. JOURNAL OF NEUROLOGY
- Riluzole increases the rate of glucose transport in L6 myotubes and NSC-34 motor neuron-like cells via AMPK pathway activation
- (2013) Bareket Daniel et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Demystifying Brain Penetration in Central Nervous System Drug Discovery
- (2012) Li Di et al. JOURNAL OF MEDICINAL CHEMISTRY
- Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
- (2011) M. Cuadrado-Tejedor et al. CURRENT MEDICINAL CHEMISTRY
- Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
- (2011) Arie Neymotin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Entropic Stabilization of Proteins by TMAO
- (2011) Samuel S. Cho et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
- (2011) Amanda M Haidet-Phillips et al. NATURE BIOTECHNOLOGY
- Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
- (2010) Jeffrey D. Rothstein ANNALS OF NEUROLOGY
- Chemical and Pharmacological Chaperones: Application for Recombinant Protein Production and Protein Folding Diseases
- (2010) Rahul S. Rajan et al. CURRENT MEDICINAL CHEMISTRY
- Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
- (2010) Daryl A Bosco et al. NATURE NEUROSCIENCE
- Mutant superoxide dismutase 1 overexpression in NSC-34 cells: Effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins
- (2010) Catarina Gomes et al. NEUROSCIENCE LETTERS
- Metabolism of Pyridalyl in Rats: Excretion, Distribution, and Biotransformation of Dichloropropenyl-Labeled Pyridalyl
- (2009) Hirohisa Nagahori et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Amyotrophic lateral sclerosis
- (2009) Lokesh C Wijesekera et al. Orphanet Journal of Rare Diseases
- Synthesis of 2-aryl-6-methyl-5-nitroquinoline derivatives as potential prodrug systems for reductive activation
- (2008) Gavin D. Couch et al. TETRAHEDRON
- Strategic approaches to developing drug treatments for ALS
- (2007) A VINCENT DRUG DISCOVERY TODAY
- Blood–brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS
- (2007) Sou Okuno et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started